paricalcitol
Generic: PARICALCITOL·Brand: PARICALCITOL, ZEMPLAR
paricalcitol: 1 clinical trial tracked.
paricalcitol evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about paricalcitol, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Primary endpoint: Percentage of Participants Who Achieve Positive Response During Dosing Period 1
Interventionalopen2 targetStarted 2020-09Completion 2025-0615 sites · Puerto Rico, United StatesAbbVie